Indeed, tumors over-expressing TRF2 showed reduced levels of LC3, associated with an accumulation of p62 SQSTM1, upon drug exposure (Fig. 3c-d), confirming that reduction of tumor volume observed in response to treatment is largely attributableto a robust impairment of TRF2-dependent autophagy activation. The gene discussed is SQSTM1; the disease is neoplasm.